AbbVie CEO Upbeat On Skyrizi Commercialization, Raises Financial Guidance

Steps
Product approvals and increasing revenues are buoying AbbVie, but biosimilar concerns with Humira remain • Source: Shutterstock

More from Business

More from Scrip